| Typicality: | 0.641 |
| Saliency: | 0.536 |
| between placebo | 4 | other |
| prior to intervention | 4 | temporal |
| to a 60 minute infusion rate | 3 | other |
| subject → be → randomized | 170 |
| subject → be → randomised | 14 |
| negative | neutral | positive |
| 0.108 | 0.852 | 0.040 |
| Raw frequency | 184 |
| Normalized frequency | 0.536 |
| Modifier score | 1.000 |
| Perplexity | 75.173 |